Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...

and commercializing novel treatments for B-cell diseases. Its portfolio includes azercabtagene zapreleucel (azer-cel), an allogenic CD19 CAR-T cell therapy for treating autoimmune diseases and ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

Asthma a chronic respiratory condition may be driven by specific immune cells that influence inflammation and severity ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...

Researchers find that certain antioxidant enzymes, called selenoproteins, significantly contribute to fighting cell aging. The team used a gene knockout mouse model to help them study the effects of ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...